Moonbase
← Back to Awards
NATIONAL CANCER INSTITUTENIH · NATIONAL CANCER INSTITUTENIH

Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression

Coffey, Robert J. (Contact)·Vanderbilt University Medical Center, TN·2022–2027·ACTIVE
Donate

INSTITUTION

Vanderbilt University Medical Center, TN

PRINCIPAL INVESTIGATOR

Coffey, Robert J. (Contact)

FUNDING

$281K

YEAR

2022

MOONBASE SCORE

Still being scored

LOADING MOONBASE SCORE

Abstract

PROJECT SUMMARY/ABSTRACT Project 1: Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression Project 1 aims to examine how shaping the microenvironment by DPEP1 facilitates adenoma progression. This will be a basic project. We propose that dipeptidase-1 (DPEP1) marks those adenomas with the potential to progress to colorectal cancer (CRC) through an active bi-directional communication with neutrophils. DPEP1 has two functions: dipeptidase activity and recently identified neutrophil-binding activity. Our hypothesis is that DPEP1, largely through its neutrophil-binding activity, marks adenomas with a predilection for progression. We have found that DPEP1 immunoreactivity is detected in 27% of colorectal adenomas but this increases to 72% of CRCs, consistent with DPEP1 marking the small subset of adenomas that progress to CRC. Utilizing human specimens, a unique Transwell co-culture system of adenoma organoids and freshly isolated neutrophils isolated from healthy volunteers, and an informative mouse model, we will test if DPEP1-expressing adenomas more effectively communicate with neutrophils and create a neutrophil-enriched microenvironment, increasing the likelihood that these adenomas will progress. Exosomes have attracted a great deal of recent attention as a rich source of cargo that may serve as cancer biomarkers. We have found that DPEP1 is released in exosomes from CRC cell lines and that it highly enriched in a subset of exosomes that contain known CRC biomarkers, CEA and EPCAM. Of interest, neutrophils also release small extracellular vesicles (sEVs) that contain neutrophil elastase in a form that cannot be inhibited by elastase inhibitors, and thus it is especially potent in degrading the extracellular matrix, a key step in cancer invasion. We will also use a unique neutrophil reporter mouse to monitor onset and perdurance of neutrophil infiltration, along with the properties of these neutrophils, in an inducible, stem cell-driven mouse model of colonic adenomas. .

NATIONAL CANCER INSTITUTEU54ZCA1-SRB-2throughfunctionshumanalonginfiltrationlikelihoodmarkingpropertiesexosomesbiomarkersadenomascolonicsummarysfdlinesrecenttranswellelastase

Are you the primary organization running this research?

The two tools below are built for the principal investigator & host institution behind this project.